Ditchcarbon
  • Contact
  1. Organizations
  2. PROCAPS
Public Profile
Pharmaceutical Preparation Manufacturing
CO
updated 3 months ago

PROCAPS Sustainability Profile

Company website

PROCAPS, officially known as PROCAPS S.A., is a leading pharmaceutical and nutraceutical company headquartered in Colombia. Established in 1977, PROCAPS has grown to become a prominent player in the Latin American market, with significant operations across Colombia and other key regions. The company is renowned for its innovative softgel technology, which sets its products apart in the industry. Specialising in the development and manufacturing of high-quality dietary supplements and pharmaceutical products, PROCAPS focuses on enhancing health and wellness through science-driven solutions. With a commitment to quality and sustainability, the company has achieved notable milestones, including certifications from international regulatory bodies. PROCAPS continues to solidify its market position, recognised for its dedication to research and development, making it a trusted name in the pharmaceutical and nutraceutical sectors.

DitchCarbon Score

How does PROCAPS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

PROCAPS's score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

37%

Let us know if this data was useful to you

PROCAPS's reported carbon emissions

PROCAPS, headquartered in Colorado, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As there is no emissions data available, it is unclear how PROCAPS is addressing its carbon footprint or what specific initiatives are in place to mitigate climate impact. The lack of reported emissions and reduction strategies suggests that PROCAPS may still be in the early stages of developing a comprehensive climate action plan. In the context of the industry, many companies are increasingly focusing on transparency and accountability regarding their carbon emissions, and PROCAPS may need to align with these trends to enhance its sustainability profile.

How Carbon Intensive is PROCAPS's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. PROCAPS's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is PROCAPS's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for PROCAPS is in CO, which has a low grid carbon intensity relative to other regions.

PROCAPS's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

PROCAPS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare PROCAPS's Emissions with Industry Peers

Hypera Pharma

BR
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Procter And Gamble

US
•
Chemicals nec
Updated 4 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Genomma Lab Internacional

MX
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251112.6
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy